When previously sealed files tied to Jeffrey Epstein surfaced, computer scientist Scott Aaronson was surprised to find his name recurring. In 2010, while at MIT, he received an inquiry through a proxy offering to fund a research project. He had never met Epstein; after his mother warned him, he declined the approach.
Epstein, who lacked scientific credentials, nevertheless positioned himself as a patron of science. He bankrolled an exclusive 2006 physics conference and provided grants to researchers, cultivating ties to scientists and institutions. Experts say those charitable gestures helped him burnish his reputation and create networks that obscured his crimes.
Private philanthropy is a substantial source of support for US research. Estimates place private giving at roughly 20 percent of research funding at some institutions. Yet the system operates with limited transparency and few standardized oversight mechanisms, creating openings for donors to influence fields or rehabilitate their public image without much public scrutiny.
Stanford professor Rob Reich, who studies philanthropy’s impact on democracy, argues that lack of transparency is a major failing. Because legal disclosure requirements are narrow, much of the vetting responsibility falls to universities and individual researchers. That decentralized approach means many donations receive only light review unless they are unusually large or tied to prominent naming rights.
Jeffrey Flier, former dean of Harvard Medical School, says reputational risk was not top of mind for many academics before the Epstein revelations. Fundraising can dominate the time of senior administrators, and incoming offers of support often trigger a practical response: the money could enable important research. As a result, institutions tend to concentrate their most rigorous scrutiny on the biggest gifts and those carrying naming opportunities.
Universities do publish donor policies and perform reputational checks, says Roger Ali of the Association of Fundraising Professionals, but critics describe enforcement as uneven. Epstein’s approach sometimes involved a mix of large and many smaller gifts, a structure that can attract less attention over time.
After Epstein’s crimes became public, some institutions pledged greater transparency, but structural change has been limited. Reich cites the example of the Sackler family’s donations, linked to the opioid crisis, to show how philanthropy can obscure harmful conduct. He advocates requiring private universities to disclose donor identities, gift amounts, and any restrictions or intended uses attached to donations.
Reich acknowledges that not all giving should be treated the same—there are instances where donors who committed wrongdoing later give as a form of atonement—but he argues decisions about accepting such gifts should be public and deliberative rather than ad hoc.
Those who defend the current framework urge caution about sweeping reforms. Fundraisers and university officials emphasize existing checks and note that philanthropic support does enormous good for research and education. Still, the Epstein case has reinvigorated calls for clearer norms and more consistent disclosure so the influence of private money on science is visible and open to public debate.
The central question remains how to balance the benefits of private funding with safeguards that protect scientific independence and institutional reputation. Increasing transparency about donor policies, gift terms, and institutional vetting could help create a more accountable system without eliminating the philanthropic support that many research programs rely on.